🔎 Trials Near Me

Pradžia › Autoimuninės ligos › Washington

Autoimuninės ligos klinikiniai tyrimai Washington

8 tyrimai dėl Autoimuninės ligos ieško dalyvių vietose Washington.

Miestai Washington

Oficialus tyrimo tekstas (anglų kalba)

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06817889

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • Arthritis Northwest PLLC, Spokane
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07621809

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • University of Washingto, Seattle
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • Seattle Children's Research Institute - Accepting Juvenile Patients, Seattle
Renkami dalyviai2/3 fazė
Amžius nuo 6 iki 75 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06154252

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Renkami dalyviai2 fazė
Amžius nuo 18 iki 69 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07699380

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • University of Washingto, Seattle
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06948318

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • Swedish Neuroscience Research, Seattle
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06359041

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Fred Hutchinson Cancer Research Center, Seattle
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.